health biotech news today obesity drugs glp-1 Agonists Weight Loss Market Report, 2025-2030 Why GLP-1 drugs are changing

Lilly reportedly plans to seek FDA approval for this use and if approved, the drug would be the first pharmaceutical treatment on the market for sleep apnea

The Joi + Blokes GLP-1 page includes this disclosure directly on the product page

44 There are ongoing studies evaluating the efficacy of orforglipron on weight loss and cardiovascular outcomes (clinical trial number NCT05803421

Are GLP-1s better than metformin

A Safer Next Step: Medically Supervised Weight Loss in Doral If you are drawn to glp patches because medication access feels expensive or intimidating, you are not alone, and you are not wrong to want something simpler

Larger molecules typically have lower breast milk transfer, but exact human excretion rates remain unknown